Your session is about to expire
← Back to Search
PRP Injection for Diminished Ovarian Reserve(PRP4POA Trial)
PRP4POA Trial Summary
This trial will test whether Platelet Rich Plasma (PRP) can improve ovarian reserve in women with poor ovarian reserve. Women will be randomly assigned to treatment with either PRP or Platelet Poor Plasma (PPP).
- Diminished Ovarian Reserve
PRP4POA Trial Eligibility Criteria
Inclusion CriteriaYou will be eligible if you check “Yes” for the criteria below
PRP4POA Trial Timeline
Study ObjectivesOutcome measures can provide a clearer picture of what you can expect from a treatment.
PRP4POA Trial Design
Find a Location
Who is running the clinical trial?
- You want to become pregnant through IVF.You want to get pregnant using IVF.
- Group 1: PPP group
- Group 2: PRP group
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Can I register for the experiment?
"This research is seeking 90 individuals with diminished ovarian reserve, lying in the age bracket of 21 to 44. To be considered for inclusion, potential study members are required to present a Follicle Stimulating Hormone level greater than 12; fewer than 6 oocytes collected through ovulation induction; an earnestness to conceive via In Vitro Fertilization techniques; Anti-Mullerian hormone lower than 1.0; and no administration of Aspirin or Motrin within seven days prior to treatment commencement."
What are the registration requirements for this experiment?
"Clinicaltrials.gov attests that this clinical trial is currently open for enrollment, with the initial post on February 24th 2020 and a recent update provided in November 2021."
Are individuals over 20 eligible for this research endeavor?
"In agreement with the trial's prerequisites, participants must be between 21 and 44 years old."
What is the scope of participation in this research endeavor?
"Affirmative. Clinicaltrials.gov states that this clinical trial, which was first posted on February 24th 2020, is recruiting patients. 90 individuals from 1 medical centre need to be enrolled in the study."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
Why did patients apply to this trial?
How responsive is this trial?
Typically responds via
Most responsive sites:
- Center for Human Reproduction: < 24 hours
Average response time
- < 2 Days
Share this study with friends